TMS for Exposure Therapy Resistant OCD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

TMS for Exposure Therapy Resistant OCD — Stella

Recruiting

Back to 1 Hz Real rTMS to the Pre-SMA trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(8 sites)

Netherlands

Amsterdam UMC, location VU Medical Center, Amsterdam, North Holland

GGZ inGeest, Amsterdam

Neurocare, Eindhoven

Neurocare, Groningen

Maastricht UMC+, Maastricht

Key details

Phase

Large-scale testing

Sponsor

Amsterdam UMC, location VUmc

Collaborators

GGZ inGeest, Radboud University Medical Center

Enrollment target

~250 participants

Started

May 2022

Primary completion

December 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov